CDH First in Illinois to Offer Proton Therapy
Joint Venture Formed to Offer Proton Therapy Cancer Treatment in 2010
WINFIELD, Ill., July 10, 2007 — Central DuPage Hospital (CDH) in Winfield, Ill., announced its intent to enter a joint venture with ProCure Treatment Centers Inc. and Radiation Oncology Consultants, Ltd. to bring the future of cancer treatment to Illinois.
"We will have the capacity to treat up to 1,500 cancer patients a year. Imagine the lives that will be impacted," said Luke McGuinness, Chief Executive Officer of CDH. "This is the most precise form of radiation treatment available. Patients will have the best treatment, from the best physicians at a Top 100 Hospital in the United States. We've worked hard to ensure Central DuPage Hospital is a place where you can focus on getting well."
Proton therapy will be available on an out-patient basis. It has applications for most solid tumors, including tumors of the head, neck and pelvis, cancers of the eye and prostate. Nearly all U.S. insurance providers cover proton therapy as does the U.S Medicare program.
Nearly 50,000 people worldwide have received proton therapy at centers in Europe, Asia and the United States. This center will be the eighth in the United States and the first in Illinois.
The Winfield-based center will have four treatment rooms. The Letter of Intent has been filed with the State of Illinois, and pending regulatory approval, patient treatment is expected by 2010.
For more information, visit www.ProtonTherapyIllinois.com.
About ProCure Treatment Centers, Inc.
ProCure Treatment Centers, Inc., based in Bloomington, Ind., was founded in 2005 by Dr. John Cameron, a particle therapy physics pioneer who was pivotal in the development of the Midwest Proton Radiotherapy Institute. ProCure provides management support and a model for the complete design, construction, operation and maintenance of world-class proton therapy centers.
Through partnerships with leading radiation oncologists and hospitals, ProCure's business model reduces the time, effort and cost involved in creating a facility, which allows physicians more time to focus on patient care. ProCure plans to increase the number of centers across the country to make proton therapy affordable and accessible to patients who would benefit from the treatment. For more information visit www.ProCureCenters.com.
About Radiation Oncology Consultants Limited
Radiation Oncology Consultants Limited (ROCL), with headquarters in Park Ridge, Ill., is one of the largest private practice radiation oncology practices in the Chicago area.
The practice, composed of 12 board certified radiation oncology physicians who provide cancer care to patients at multiple locations, has been an early adopter of leading technologies used in the treatment of cancer. These technologies include: 3-dimensional conformal radiation therapy (3DCRT), intensity modulated radiation therapy (IMRT), Gamma Knife radiosurgery and, soon, proton therapy. For more information, visit www.chicagocancer.com.
About Central DuPage Hospital
Central DuPage Hospital is a nationally recognized 361-bed facility located in Winfield, Illinois, a suburb west of Chicago. It is a leading center for surgical innovations and was one of the first institutions in the nation to offer minimally invasive heart surgery, robotic-assisted surgery, minimally invasive spine surgery with bio-engineered bone protein and was the first Level III Neonatal Intensive Care Unit in DuPage County.
The hospital is an interdependent network of health-care organizations and services, including convenient care centers, occupational health services and a full range of options for senior living, home health and hospice care. For more information or to find a doctor, visit www.cdh.org or call (630) 933-4CDH.
Amy Jo Steinbruecker
Central DuPage Hospital
Email the Media Contact